Thursday, November 19, 2026
  • Home
  • About us
  • Privacy policy
  • Advertise with us
  • Contact us
Fii News Logo
No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • ASEANFastest Growing
Newsletter
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • ASEANFastest Growing
Fiinews
No Result
View All Result
Home Markets

Markets: Dr Athalye to drive growth for Kashiv BioSciences in US, Europe and Asia

Fiinews by Fiinews
November 2, 2024
in Markets
Reading Time: 2 mins read
A A
0
Kashiv BioSciences

Dr Sandeep_Athalye.

0
SHARES
20
VIEWS
LinkedinShare on Twitter

Patels accelerate growth in expanding biosimilars sector

New Jersey-based Kashiv BioSciences, LLC, says Dr Sandeep Nilkanth Athalye as Global Chief Executive Officer will oversee operations and drive strategic growth across key markets, including the United States, Europe and Asia.

“We are confident that Dr Athalye’s industry expertise and leadership will be instrumental in achieving Kashiv’s ambitious global vision,” said Chirag and Chintu Patel, Co-Founders and Board Members of Kashiv BioSciences which also has operations in India https://sbi.com.in/.

“We are delighted to welcome Dr Athalye to Kashiv. His appointment comes at a pivotal time as we accelerate our growth in the rapidly expanding biosimilars sector,” they said on 1 Nov, highlighting the seasoned leader’s two decades of experience in strategic and operational roles within the global pharmaceutical industry https://www.nseindia.com/.

Dr Athalye, Global CEO, stated, “Kashiv is an ambitious biosimilars company founded with a vision to bring affordable and accessible biosimilars globally https://www.bseindia.com/.

“Kashiv has a clear objective to be among the top biosimilars players with a differentiated pipeline and state-of-the-art manufacturing and R&D facilities in the US and India. I am very excited for the opportunity to use technology and innovation to drive Kashiv to become one of the leading developers of medicines in the biologics space https://www.ibef.org/,” he said.

Dr Athalye’s previous leadership roles span Biocon Biologics, Boehringer Ingelheim, Novartis, and Schering-Plough Research Institute https://www.cii.in/.

Dr Athalye is recognized for his focus on innovative, patient-centric strategies and his commitment to sustainable growth. His background in clinical development, regulatory strategy, and R&D provides a unique perspective and positions him well to lead Kashiv into its next phase of expansion. His ability to foster collaborative environments and build high-performing teams has consistently yielded outstanding results https://www.makeinindia.com/home/.

Kashiv BioSciences, LLC is a fully-integrated biopharmaceutical company. Kashiv BioSciences, LLC in the United States, and its subsidiary, Kashiv BioSciences Private Limited in India (together “Kashiv BioSciences”) operate together with robust infrastructure and highly skilled teams that provide global R&D, clinical, manufacturing, regulatory, and IP capabilities https://www.conexpoconagg.com/. Fiinews.com

Tags: Kashiv BioSciences
ShareTweetShare

Related Posts

Bearingpoint
Markets

Market: Urban consumers prefer electric mobility

by Fiinews
November 19, 2026
0
18

39% Indians prefer BEV, says Schuler India may be on the verge of becoming the next major electric mobility market...

Rootstock
Markets

Market: Rootstock expands in India through Conserve

by Fiinews
November 19, 2026
0
17

Manufacturing executives need a platform that connects their front office to production line, says Parija Rootstock Software, a recognized leader...

HGS logo

Market: HGS-Rackspace to grow in high-value GCCs

November 18, 2026
27
Hanon Systems

Market: Hanon reinforced commitment to India

November 16, 2026
18
DFI

Market: Drone industry set to grow to Rs.97,300cr

November 16, 2026
20
ITPO

Market: Indians urged to do global business

November 16, 2026
21
SBI YONO

Recent News

  • Invest: Italian companies keen on India
  • Invest: Perma-Pipe acquires 51% of Welspun unit
  • Invest: KKR takes minority stake in Gentari
  • Project: MoD inks contract with Israel Aerospace Industries
  • Market: Urban consumers prefer electric mobility

Pages

  • About US
  • ADVERTISE ON FIINEWS.COM
  • CONTACT US
  • EVENTS
  • FII-NEWS.COM PDF ARCHIVE
  • Home
  • News
  • PRIVACY POLICY
  • About
  • Advertise
  • Careers
  • Contact us

© 2026 FIINEWS - Design and developed by 7clicksmedia.

No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • ASEAN

© 2026 FIINEWS - Design and developed by 7clicksmedia.